IC
BMY icon

IKOS CIF’s Bristol-Myers Squibb BMY Stock Holding History

IKOS CIF’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$114K Buy
+2,120
New +$136K 0.68% 41
2016
Q1 		– Sell
-1,511
Closed -$103K – 183
2015
Q4 		$103K Buy
+1,511
New +$99.9K 0.32% 114
2014
Q4 		– Sell
-4,441
Closed -$229K – 234
2014
Q3 		$229K Buy
+4,441
New +$222K 0.33% 123

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

IKOS CIF's BMY Position: Q3 2016 in Review

IKOS CIF opened a new position in Bristol-Myers Squibb (BMY) in Q3 2016: 2,120 shares worth $114K. The stake represents 0.68% of the portfolio and ranks #41 among its holdings. This is a return to the name: IKOS CIF previously reported a position in BMY as recently as Q4 2015.

IKOS CIF first reported a position in BMY in Q3 2014 and has held it in 3 quarters since. The position peaked at $229K in Q3 2014. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • IKOS CIF held 2,120 shares of Bristol-Myers Squibb worth $114K as of Q3 2016.
  • Bristol-Myers Squibb was a new IKOS CIF position in Q3 2016.
  • Bristol-Myers Squibb made up 0.68% of IKOS CIF's portfolio in Q3 2016, its #41 holding.
  • IKOS CIF first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 3 quarters since.
  • IKOS CIF's Bristol-Myers Squibb position peaked at $229K in Q3 2014.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on IKOS CIF's 13F filing for Q3 2016, filed 10 Nov 2016.